Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC
Ontology highlight
ABSTRACT: Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC
PROVIDER: PRJNA750129 | ENA |
REPOSITORIES: ENA
ACCESS DATA